A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer
Keywords: سرطان متاستاتیک سینه; Bevacizumab; Gemcitabine; Metastatic breast cancer; Paclitaxel; Phase II